Plasmid contains the entire genome of HIV-1 with a specific mutation in the protease gene, which has been described as a polymorphic mutation. It is unclear, whether it can confer drug resistance to specific HIV-1 PR inhibitors directly. It has been shown in cell culture that the presence of the 63P change leads to higher "replicative fitness" of the virus. The respective mutations have been reported in viruses from HIV-infected individuals on PR inhibitors with virologic therapy failure.
Infectious cell culture supernatant containing Human Parechovirus A6
(PEV-A6/Netherlands/10008/2014). This strain is preserved in viral storage medium -80°C.
"Infectious cell culture supernatant containing Human Parechovirus A4
(PEV-A4/Netherlands/10007/2014). This strain is preserved in viral storage medium -80°C."
"Infectious cell culture supernatant containing Coxsackievirus A9
(CV-A9/Netherlands/10000/2018). This strain is preserved in viral storage medium -80°C."
Infectious cell culture supernatant containing Human Parechovirus A5
(PEV-A5/Netherlands/10018/2014). This strain is preserved in viral storage medium -80°C.
"Infectious cell culture supernatant containing Coxsackievirus A6
(CV-A6/Netherlands/10014/1965). This strain is preserved in viral storage medium -80°C."
Infectious cell culture supernatant. This Toscana virus (strain ISS Phl.3) is freez dried. Tests for the presence of mycoplasmae were negative. To confirm its identity the virus has been fully sequenced.
Infectious cell culture supernatant. This Toscana virus (strain ISS Phl.3) is preserved under Viral Storage Medium -80C. Tests for the presence of mycoplasmae were negative.
Infectious cell culture supernatant. This historical isolate, Ukauwa virus is freeze dried. The virus is mycoplasma free. To confirm its identity the virus has fully sequenced.
